access your medical records
Home > Research at Avera > Clinical Trials at Avera > Clinical Trials Search Results
This phase II/III trial compares the usual treatment with radiation therapy and temozolomide to radiation therapy in combination with immunotherapy with ipilimumab and nivolumab in treating patients with newly diagnosed MGMT unmethylated glioblastoma.
Compassionate Use in advanced cancer patients with MAPK pathway-altered solid tumor(s), including but not limited to KRAS, NRAS, HRAS, BRAF, MEK, and ERK mutations
© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.